Liquidia (LQDA) Non-Current Debt (2019 - 2022)
Liquidia's (LQDA) quarterly Non-Current Debt came in at $19.9 million in Q4 2022, up 90.96% year-on-year from $10.4 million in Q4 2021, and up 0.7% quarter-over-quarter from $19.7 million in Q3 2022.
Liquidia (LQDA) Non-Current Debt (2019 - 2022) Analysis & Trends
Liquidia's Non-Current Debt history runs 4 years deep, the most recent figure standing at $19.9 million for Q4 2022.
- On a quarterly basis, Non-Current Debt rose 90.96% year-over-year to $19.9 million in Q4 2022; TTM through Dec 2022 was $19.9 million, a 90.96% increase from a year earlier, with the FY2022 full-year figure at $19.9 million, up 90.96% from the prior year.
- Non-Current Debt climbed to $19.9 million in Q4 2022 per LQDA's latest filing, from $19.7 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $19.9 million in Q4 2022 and bottomed at $10.2 million in Q1 2021.
- The 4-year median for Non-Current Debt is $10.4 million (2021), against an average of $14.0 million.
- Across the five-year window, Non-Current Debt gained 0.0% in 2020 and jumped 91.38% in 2022, its largest moves.
- Year by year, Non-Current Debt stood at $10.3 million in 2019, then increased by 0.0% to $10.3 million in 2020, then gained by 1.14% to $10.4 million in 2021, then soared by 90.96% to $19.9 million in 2022.
- Per Business Quant, the three latest LQDA Non-Current Debt figures stand at $19.9 million (Q4 2022), $19.7 million (Q3 2022), and $19.6 million (Q2 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 10.34 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 14.02 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 27.86 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 12.41 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.74 Bn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 19.88 Mn |
| Sep 30, 2022 | 19.74 Mn |
| Jun 30, 2022 | 19.61 Mn |
| Mar 31, 2022 | 19.48 Mn |
| Dec 31, 2021 | 10.41 Mn |
| Sep 30, 2021 | 10.33 Mn |
| Jun 30, 2021 | 10.25 Mn |
| Mar 31, 2021 | 10.18 Mn |
| Dec 31, 2020 | 10.29 Mn |
| Dec 31, 2019 | 10.29 Mn |